BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 15589517)

  • 1. MK801 and amantadine exert different effects on subthalamic neuronal activity in a rodent model of Parkinson's disease.
    Allers KA; Bergstrom DA; Ghazi LJ; Kreiss DS; Walters JR
    Exp Neurol; 2005 Jan; 191(1):104-18. PubMed ID: 15589517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multisecond oscillations in the subthalamic nucleus: effects of apomorphine and dopamine cell lesion.
    Allers KA; Kreiss DS; Walters JR
    Synapse; 2000 Oct; 38(1):38-50. PubMed ID: 10941139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subthalamic high frequency stimulation resets subthalamic firing and reduces abnormal oscillations.
    Meissner W; Leblois A; Hansel D; Bioulac B; Gross CE; Benazzouz A; Boraud T
    Brain; 2005 Oct; 128(Pt 10):2372-82. PubMed ID: 16123144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deep brain stimulation of the pedunculopontine tegmental nucleus modulates neuronal hyperactivity and enhanced beta oscillatory activity of the subthalamic nucleus in the rat 6-hydroxydopamine model.
    Alam M; Heissler HE; Schwabe K; Krauss JK
    Exp Neurol; 2012 Jan; 233(1):233-42. PubMed ID: 22036687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine depletion increases the power and coherence of beta-oscillations in the cerebral cortex and subthalamic nucleus of the awake rat.
    Sharott A; Magill PJ; Harnack D; Kupsch A; Meissner W; Brown P
    Eur J Neurosci; 2005 Mar; 21(5):1413-22. PubMed ID: 15813951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subthalamic nucleus lesions alter basal and dopamine agonist stimulated electrophysiological output from the rat basal ganglia.
    Zahr NM; Martin LP; Waszczak BL
    Synapse; 2004 Nov; 54(2):119-28. PubMed ID: 15352137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing extracellular potassium results in subthalamic neuron activity resembling that seen in a 6-hydroxydopamine lesion.
    Strauss U; Zhou FW; Henning J; Battefeld A; Wree A; Köhling R; Haas SJ; Benecke R; Rolfs A; Gimsa U
    J Neurophysiol; 2008 Jun; 99(6):2902-15. PubMed ID: 18385482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local field potential beta activity in the subthalamic nucleus of patients with Parkinson's disease is associated with improvements in bradykinesia after dopamine and deep brain stimulation.
    Ray NJ; Jenkinson N; Wang S; Holland P; Brittain JS; Joint C; Stein JF; Aziz T
    Exp Neurol; 2008 Sep; 213(1):108-13. PubMed ID: 18619592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rhythm-specific pharmacological modulation of subthalamic activity in Parkinson's disease.
    Priori A; Foffani G; Pesenti A; Tamma F; Bianchi AM; Pellegrini M; Locatelli M; Moxon KA; Villani RM
    Exp Neurol; 2004 Oct; 189(2):369-79. PubMed ID: 15380487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nigrostriatal lesion and dopamine agonists affect firing patterns of rodent entopeduncular nucleus neurons.
    Ruskin DN; Bergstrom DA; Walters JR
    J Neurophysiol; 2002 Jul; 88(1):487-96. PubMed ID: 12091570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subthalamic stimulation and neuronal activity in the substantia nigra in Parkinson's disease.
    Maltête D; Jodoin N; Karachi C; Houeto JL; Navarro S; Cornu P; Agid Y; Welter ML
    J Neurophysiol; 2007 Jun; 97(6):4017-22. PubMed ID: 17460099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basal ganglia neural responses during behaviorally effective deep brain stimulation of the subthalamic nucleus in rats performing a treadmill locomotion test.
    Shi LH; Luo F; Woodward DJ; Chang JY
    Synapse; 2006 Jun; 59(7):445-57. PubMed ID: 16521122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subthalamic responses to amphetamine and apomorphine in the behaving rat with a unilateral 6-OHDA lesion in the substantia nigra.
    Olds ME; Jacques DB; Kopyov O
    Synapse; 1999 Dec; 34(3):228-40. PubMed ID: 10523760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-frequency stimulation of the subthalamic nucleus modulates the activity of pedunculopontine neurons through direct activation of excitatory fibres as well as through indirect activation of inhibitory pallidal fibres in the rat.
    Florio T; Scarnati E; Confalone G; Minchella D; Galati S; Stanzione P; Stefani A; Mazzone P
    Eur J Neurosci; 2007 Feb; 25(4):1174-86. PubMed ID: 17331213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrasubthalamic injection of 6-hydroxydopamine induces changes in the firing rate and pattern of subthalamic nucleus neurons in the rat.
    Ni Z; Bouali-Benazzouz R; Gao D; Benabid AL; Benazzouz A
    Synapse; 2001 May; 40(2):145-53. PubMed ID: 11252026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta oscillatory activity in the subthalamic nucleus and its relation to dopaminergic response in Parkinson's disease.
    Weinberger M; Mahant N; Hutchison WD; Lozano AM; Moro E; Hodaie M; Lang AE; Dostrovsky JO
    J Neurophysiol; 2006 Dec; 96(6):3248-56. PubMed ID: 17005611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuronal firing activity and gene expression changes in the subthalamic nucleus after transplantation of dopamine neurons in hemiparkinsonian rats.
    Rumpel R; Alam M; Klein A; Özer M; Wesemann M; Jin X; Krauss JK; Schwabe K; Ratzka A; Grothe C
    Neurobiol Dis; 2013 Nov; 59():230-43. PubMed ID: 23938762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrophysiological alterations in subthalamic neurons after unilateral dopamine depletion in the rat.
    Gajendiran M; Cepeda C; Kha HT; Sison JD; Levine MS
    J Neurosci Res; 2005 Apr; 80(2):203-10. PubMed ID: 15765528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of 6-hydroxydopamine-induced severe or partial lesion of the nigrostriatal pathway on the neuronal activity of pallido-subthalamic network in the rat.
    Breit S; Bouali-Benazzouz R; Popa RC; Gasser T; Benabid AL; Benazzouz A
    Exp Neurol; 2007 May; 205(1):36-47. PubMed ID: 17395181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subthalamic oscillatory activities at beta or higher frequency do not change after high-frequency DBS in Parkinson's disease.
    Foffani G; Ardolino G; Egidi M; Caputo E; Bossi B; Priori A
    Brain Res Bull; 2006 Mar; 69(2):123-30. PubMed ID: 16533660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.